A review on Millepachine and its derivatives as potential multitarget anticancer agents
- Authors
- Rampogu, Shailima; Badvel, Pallavi; Hoon Jo, Byung; Kim, Yongseong; Kim, Seon-Won; Lee, Keun Woo
- Issue Date
- Nov-2023
- Publisher
- Elsevier B.V.
- Keywords
- G2/M arrest; Millepachine; Millepachine and its derivatives; Natural compounds; Tubulin polymerization
- Citation
- Biochemical and Biophysical Research Communications, v.681, pp 249 - 270
- Pages
- 22
- Indexed
- SCIE
SCOPUS
- Journal Title
- Biochemical and Biophysical Research Communications
- Volume
- 681
- Start Page
- 249
- End Page
- 270
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/68247
- DOI
- 10.1016/j.bbrc.2023.09.044
- ISSN
- 0006-291X
1090-2104
- Abstract
- Chalcones have a long history of being used for many medical purposes. These are the most prestigious scaffolds in medicine. The potential of Millepachine and its derivatives to treat various malignancies has been demonstrated in this review. The anticancer effects of Millepachine and its derivatives on ovarian cancer, hepatocellular carcinoma, breast, liver, colon, cervical, prostate, stomach, and gliomas are highlighted in the current review. Several genes that are crucial in reducing the severity of the disease have been altered by these substances. They mainly work by preventing tubulin polymerizing. They also exhibit apoptosis and cell cycle arrest at the G2/M phase. Additionally, these compounds inhibit invasion and migration and have antiproliferative effects. Preclinical studies have shown that Millepachine and its derivatives offer exceptional potential for treating a number of cancers. These results need to be confirmed in clinical research in order to develop viable cancer therapies. © 2023 Elsevier Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 자연과학대학 > Division of Life Sciences > Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.gnu.ac.kr/handle/sw.gnu/68247)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.